Cargando…
A comparison of the efficacy of darifenacin alone vs. darifenacin plus a Behavioural Modification Programme upon the symptoms of overactive bladder
PURPOSE: This study assessed the benefit of adding behavioural modification to darifenacin treatment for overactive bladder (OAB). MATERIALS AND METHODS: The ABLE trial was a randomised, open-label, parallel-group, multicentre study of 12 weeks of darifenacin treatment [with voluntary up-titration f...
Autores principales: | Chancellor, M B, Kianifard, F, Beamer, E, Mongay, L, Ebinger, U, Hicks, G, DelConte, A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2325270/ https://www.ncbi.nlm.nih.gov/pubmed/18324952 http://dx.doi.org/10.1111/j.1742-1241.2008.01714.x |
Ejemplares similares
-
Treatment of overactive bladder in the aging population: focus on darifenacin
por: Jha, Swati, et al.
Publicado: (2006) -
Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin
por: Kay, G G, et al.
Publicado: (2008) -
Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin
por: Chughtai, Bilal, et al.
Publicado: (2008) -
Darifenacin hydrobromide
por: Selvanayagam, S., et al.
Publicado: (2009) -
Darifenacin treatment for overactive bladder in patients who expressed dissatisfaction with prior extended-release antimuscarinic therapy
por: Zinner, N, et al.
Publicado: (2008)